PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery.


Journal

Journal of chemical information and modeling
ISSN: 1549-960X
Titre abrégé: J Chem Inf Model
Pays: United States
ID NLM: 101230060

Informations de publication

Date de publication:
25 Feb 2024
Historique:
medline: 26 2 2024
pubmed: 26 2 2024
entrez: 26 2 2024
Statut: aheadofprint

Résumé

PandaOmics is a cloud-based software platform that applies artificial intelligence and bioinformatics techniques to multimodal omics and biomedical text data for therapeutic target and biomarker discovery. PandaOmics generates novel and repurposed therapeutic target and biomarker hypotheses with the desired properties and is available through licensing or collaboration. Targets and biomarkers generated by the platform were previously validated in both

Identifiants

pubmed: 38404138
doi: 10.1021/acs.jcim.3c01619
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Petrina Kamya (P)

Insilico Medicine Canada Inc., 3710-1250 René-Lévesque Blvd. W, Montreal, Quebec, Canada H3B 4W8.

Ivan V Ozerov (IV)

Insilico Medicine Hong Kong Limited, Hong Kong Science and Technology Park, Hong Kong.

Frank W Pun (FW)

Insilico Medicine Hong Kong Limited, Hong Kong Science and Technology Park, Hong Kong.

Kyle Tretina (K)

Insilico Medicine Hong Kong Limited, Hong Kong Science and Technology Park, Hong Kong.

Tatyana Fokina (T)

Insilico Medicine Hong Kong Limited, Hong Kong Science and Technology Park, Hong Kong.

Shan Chen (S)

Insilico Medicine Shanghai Limited, Suite 901, Tower C, Changtai Plaza, 2889 Jinke Road, Pudong New District, Shanghai 201203, China.

Vladimir Naumov (V)

Insilico Medicine Hong Kong Limited, Hong Kong Science and Technology Park, Hong Kong.

Xi Long (X)

Insilico Medicine Hong Kong Limited, Hong Kong Science and Technology Park, Hong Kong.

Sha Lin (S)

Insilico Medicine Shanghai Limited, Suite 901, Tower C, Changtai Plaza, 2889 Jinke Road, Pudong New District, Shanghai 201203, China.

Mikhail Korzinkin (M)

Insilico Medicine Hong Kong Limited, Hong Kong Science and Technology Park, Hong Kong.

Daniil Polykovskiy (D)

Insilico Medicine Canada Inc., 3710-1250 René-Lévesque Blvd. W, Montreal, Quebec, Canada H3B 4W8.

Alex Aliper (A)

Insilico Medicine AI Limited, Level 6, Unit 08, Block A, IRENA HQ Building, P.O. Box 145748, Masdar City, Abu Dhabi, United Arab Emirates.

Feng Ren (F)

Insilico Medicine Shanghai Limited, Suite 901, Tower C, Changtai Plaza, 2889 Jinke Road, Pudong New District, Shanghai 201203, China.

Alex Zhavoronkov (A)

Insilico Medicine Hong Kong Limited, Hong Kong Science and Technology Park, Hong Kong.
Insilico Medicine AI Limited, Level 6, Unit 08, Block A, IRENA HQ Building, P.O. Box 145748, Masdar City, Abu Dhabi, United Arab Emirates.
Buck Institute for Research on Aging, Novato, California 94945, United States.

Classifications MeSH